Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: Negative interference of activated glucocorticoid receptor with transcription factors

Journal of Neuroimmunology

Volumn 109, Issue 1, 2000, Pages 16-22

  De Bosscher, Karolien ^a   Vanden Berghe, Wim ^a   Haegeman, Guy ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Glucocorticoid; Inflammation; NF B; Repression; Transcription factor

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; GENE REPRESSION; GENETIC TRANSCRIPTION; HORMONE ACTION; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA-BINDING PROTEINS; GLUCOCORTICOIDS; HUMANS; I-KAPPA B PROTEINS; IMMUNOSUPPRESSIVE AGENTS; NF-KAPPA B; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION FACTORS;

EID: 0034284349     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00297-6     Document Type: Article

References (51)

1. Aarnisalo P., Palvimo J.J., Jänne O.A. CREB-binding protein in androgen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA. 95:1998;2122-2127.
2. Adcock I.M., Nasuhara Y., Stevens D.A., Barnes P.J. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-κB and lack of IκB involvement. Br. J. Pharmacol. 127:1999;1003-1011.
3. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science. 270:1995;286-290.
4. Barnes P.J., Adcock I.M. NF-κB: a pivotal role in asthma and a new target for therapy. Trends Pharmacol. Sci. 18:1997;46-50.
5. Beato M., Herrlich P., Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 83:1995;851-857.
6. Brostjan C., Anrather J., Csizmadia V., Stroka D., Soares M., Bach F.H., Winkler H. Glucocorticoid-mediated repression of NFκB activity in endothelial cells does not involve induction of IκB-α synthesis. J. Biol. Chem. 271:1996;19612-19616.
7. Cato A.C., Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. BioEssays. 18:1996;371-378.
8. De Bosscher K., Schmitz M.L., Vanden Berghe W., Plaisance S., Fiers W., Haegeman G. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA. 94:1997;13504-13509.
9. De Bosscher, K., Vanden Berghe, W., Vermeulen, L., Plaisance, S., Boone, E., Haegeman, G., 2000. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. USA 97, in press.
10. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19:1998;269-301.
11. Dumont A., Hehner S.P., Schmitz M.L., Gustafsson J.A., Liden J., Okret S., van der Saag P.T., Wissink S., van der Burg B., Herrlich P., Haegeman G., De Bosscher K., Fiers W. Cross-talk between steroids and NF-κB: what language? Trends Biochem. Sci. 23:1998;233-235.
12. Gerritsen M.E., Williams A.J., Neish A.S., Moore S., Shi Y., Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA. 94:1997;2927-2932.
13. Ghosh S., May M.J., Kopp E.B. NF-κB and rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
14. Giguere V., Hollenberg S.M., Rosenfeld M.G., Evans R.M. Functional domains of the human glucocorticoid receptor. Cell. 46:1986;645-652.
15. Glass C.K., Rose D.W., Rosenfeld M.G. Nuclear receptor coactivators. Curr. Opin. Cell. Biol. 9:1997;222-232.
16. Grilli M., Goffi F., Memo M., Spano P. Interleukin-1β and glutamate activate the NF-κB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J. Biol. Chem. 271:1996;15002-15007.
17. Heck S., Bender K., Kullmann M., Gottlicher M., Herrlich P., Cato A.C. IκB-α-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J. 16:1997;4698-4707.
18. Hollenberg S.M., Evans R.M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell. 55:1988;899-906.
19. Horwitz K.B., Jackson T.A., Bain D.I., Richer J.K., Takimoto G.K., Tung L. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1996;1167-1177.
20. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62:1990;1189-1204.
21. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
22. Lee S.K., Kim H.J., Na S.Y., Kim T.S., Choi H.S., Im S.Y., Lee J.W. Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-jun and c-fos subunits. J. Biol. Chem. 273:1998;16651-16654.
23. Leung D.Y., de Castro M., Szefler S.J., Chrousos G.P. Mechanisms of glucocorticoid-resistant asthma. Ann. New York Acad. Sci. 840:1998;735-746.
24. Lezoualc'h F., Sagara Y., Holsboer F., Behl C. High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18:1998;3224-3232.
25. Liden J., Delaunay F., Rafter I., Gustafsson J., Okret S. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J. Biol. Chem. 272:1997;21467-21472.
26. Martinez-Balbas M.A., Bannister A.J., Martin K., Haus-Seuffert P., Meisterernst M., Kouzarides T. The acetyltransferase activity of CBP stimulates transcription. EMBO J. 17:1998;2886-2893.
27. McEwan I.J., Wright A.P., Gustafsson J.A. Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays. 19:1997;153-160.
28. Mercurio F., Manning A.M. Multiple signals converging on NF-κB. Curr. Opin. Cell. Biol. 11:1999;226-232.
29. O'Neill L.A.J., Kaltschmidt C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 220:1997;252-258.
30. Perkins N.D. Achieving transcriptional specificity with NF-κB. Int. J. Biochem. Cell. Biol. 29:1997;1433-1448.
31. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. Regulation of NFκB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:1997;523-527.
32. Pfitzner E., Jahne R., Wissler M., Stoecklin E., Groner B. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol. Endocrinol. 12:1998;1582-1593.
33. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 91:1994;752-756.
34. Scheinman R., Cogswell P.C., Lofquist A., Baldwin A.S. Role of transcriptional activation of IκB-α in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286.
35. Scheinman R.I., Gualberto A., Jewell C.M., Cidlowski J.A., Baldwin A.S. Jr. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol. Cell. Biol. 15:1995;943-953.
36. Schmitz M.L., Stelzer G., Altmann H., Meisterernst M., Baeuerle P.A. Interaction of the COOH-terminal transactivation domain of p65 NF-κB with TATA-binding protein, transcription factor IIB, and coactivators. J. Biol. Chem. 270:1995;7219-7226.
37. Sheppard K.-A., Phelps K.M., Williams A.J., Thanos D., Glass C.K., Rosenfeld M.G., Gerritsen M.E., Collins T. Nuclear integration of glucocorticoid receptor and nuclear factor-κB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273:1998;29291-29294.
38. Stein B., Cogswell P.C., Baldwin A.S. Jr. Functional and physical associations between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13:1993;3964-3974.
39. Stein B., Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBP β Mol. Cell. Biol. 15:1995;4971-4979.
40. Stöcklin E., Wissler M., Gouilleux F., Groner B. Functional interactions between stat5 and the glucocorticoid receptor. Nature. 383:1996;726-728.
41. Unlap M.T., Jope R.S. Dexamethasone attenuates NF-κB DNA binding activity without inducing IκB levels in rat brain in vivo. Brain Res. Mol. Brain Res. 45:1997;83-89.
42. Van de Stolpe A., Caldenhoven E., Raaijmakers J., Van der Saag P., Koenderman L. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am. J. Respir. Cell. Mol. Biol. 8:1993;340-347.
43. Van de Stolpe A., Caldenhoven E., Stade B.G., Koenderman L., Raaijmakers J.A., Johnson J.P., van der Saag P.T. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J. Biol. Chem. 269:1994;6185-6192.
44. Vanden Berghe W., Francesconi E., De Bosscher K., Resche-Rigon M., Haegeman G. Dissociated glucocorticoids with antiinflammatory potential repress interleukin-6 gene expression by an NF-κB-dependent mechanism. Mol. Pharmacol. 56:1999;797-806.
45. Vayssière B.M., Dupont S., Choquart A., Petit F., Garcia T., Marchandeau C., Gronemeyer H., Resche-Rigon M. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol. Endocrinol. 11:1997;1245-1255.
46. Wissink S., Meijer O., Pearce D., van der Burg B., van der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 275:2000;1321-1326.
47. Wissink S., van Heerde E.C., Schmitz M.L., Kalkhoven E., van der Burg B., Baeuerle P.A., van der Saag P.T. Distinct domains of the RelA NF-κB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J. Biol. Chem. 272:1997;22278-22284.
48. Wissink S., van Heerde E.C., vand der Burg B., van der Saag P.T. A dual mechanism mediates repression of NF-κB activity by glucocorticoids. Mol. Endocrinol. 12:1998;355-363.
49. Yamit-Hezi A., Dikstein R. TAF(II)105 mediates activation of anti-apoptotic genes by NF-κB. EMBO J. 17:1998;5161-5169.
50. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 89:1997;413-424.
51. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell. 1:1998;661-671.